TARGET ALS FOUNDATION INC: Form 990, tax year 2025
View the entire original 990 at ProPublica ↗
- Organization
- TARGET ALS FOUNDATION INC (EIN 81-0756743)
- Tax period
- 2025-01-01 to 2025-12-31
- Filed
- 2026-04-20
- IRS object ID
- 202611109349300966
- Schema version
- 2025v4.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2026-04-20T09:20:10-05:00 | ReturnTs |
| Tax Period End | 2025-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 050409384 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KAHN LITWIN RENZA & CO LTD | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 951 NORTH MAIN STREET | AddressLine1Txt |
| City | PROVIDENCE | CityNm |
| State Abbreviation | RI | StateAbbreviationCd |
| ZIP | 02904 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2025-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 810756743 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TARGET ALS FOUNDATION INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | TARG | BusinessNameControlTxt |
| Phone | 6465922541 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 244 MADISON AVE 1025 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10016 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KENNETH DEVANEY | PersonNm |
| Person Title | TREASURER | PersonTitleTxt |
| Phone | 6465922541 | PhoneNum |
| Signature | 2026-04-17 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | PATRICK J MARTIN | PreparerPersonNm |
| PTIN | P00283486 | PTIN |
| Phone | 4012742001 | PhoneNum |
| Preparation | 2026-04-17 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2025 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | KENNETH DEVANEY | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 244 MADISON AVE 1025 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10016 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $48,375,695 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | TARGETALS.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2015 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | OUR MISSION IS TO BREAK DOWN BARRIERS TO ALS RESEARCH TO FIND EFFECTIVE TREATMENTS. BY UNITING ACADEMIA, THE PHARMA AND BIOTECH INDUSTRY, GOVERNMENT, VENTURE CAPITAL, RELATED NONPROFITS, AND THE ALS COMMUNITY, WE AIM TO OVERCOME THE CHALLENGES THAT HAVE LONG HINDERED PROGRESS, BRINGING HOPE AND TANGIBLE ADVANCEMENTS TO THOSE AFFECTED BY THIS DEVASTATING DISEASE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 14 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 14 | VotingMembersIndependentCnt |
| Total Employee | 18 | TotalEmployeeCnt |
| Total Volunteers | 36 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $0 | PYContributionsGrantsAmt |
| CY Contributions Grants | $29,724,385 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $0 | PYInvestmentIncomeAmt |
| CY Investment Income | $3,535,375 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $2,225 | CYOtherRevenueAmt |
| PY Total Revenue | $0 | PYTotalRevenueAmt |
| CY Total Revenue | $33,261,985 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $18,765,868 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $0 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $3,855,667 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,758,767 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $0 | PYOtherExpensesAmt |
| CY Other Expenses | $2,997,179 | CYOtherExpensesAmt |
| PY Total Expenses | $0 | PYTotalExpensesAmt |
| CY Total Expenses | $25,618,714 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $0 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $7,643,271 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $128,911,762 | TotalAssetsBOYAmt |
| Total Assets EOY | $136,912,637 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $4,351,675 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $1,853,620 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $124,560,087 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $135,059,017 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | OUR MISSION IS TO BREAK DOWN BARRIERS TO ALS RESEARCH TO FIND EFFECTIVE TREATMENTS. BY UNITING ACADEMIA, THE PHARMA AND BIOTECH INDUSTRY, GOVERNMENT, VENTURE CAPITAL, RELATED NONPROFITS, AND THE ALS COMMUNITY, WE AIM TO OVERCOME THE CHALLENGES THAT HAVE LONG HINDERED PROGRESS, BRINGING HOPE AND TANGIBLE ADVANCEMENTS TO THOSE AFFECTED BY THIS DEVASTATING DISEASE. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $21,006,355 | ExpenseAmt |
| Grant | $18,765,868 | GrantAmt |
| Desc | RESEARCH WE FUND:TARGET ALS IS THE LARGEST AND MOST IMPACTFUL PRIVATE FUNDER OF ALS RESEARCH WORLDWIDE. THANKS TO THE GENEROUS TRUST PLACED IN US BY OUR DONORS, WE CAN DIRECT RESOURCES TO THE MOST PROMISING IDEAS AND EMERGING SCIENTIFIC LEADERS ACROSS THE GLOBE. OUR FUNDED PROJECTS HAVE A HIGH SUCCESS RATE, DELIVERING MEANINGFUL RESULTS TO ADVANCE IDEAS FROM EARLY TO LATE STAGE RESEARCH. IN 2025, WE CONTINUED TO EXPAND FUNDING OPPORTUNITIES, DRIVING NEARLY $12M INTO INNOVATION ACROSS 151 GRANTS IN THREE CRITICAL AREAS:UNDERSTANDING ALS BIOLOGY: ADVANCING INSIGHTS INTO THE ROOT CAUSES OF DISEASE TO IDENTIFY NEW DRUG TARGETS.ACCELERATING DRUG DISCOVERY: SUPPORTING PROOF-OF-CONCEPT STUDIES THAT PAVE THE WAY TOWARD CLINICAL TRIALS.DEVELOPING BIOMARKERS: ENABLING EARLIER DIAGNOSIS, IDENTIFYING ALS SUBTYPES, AND MONITORING DISEASE PROGRESSION WITH PRECISIONEVERY GRANT THAT TARGET ALS FUNDS IS TIED TO A DELIBERATE STRATEGY AND A LONG-RANGE VISION FOR THE FIELD, ENSURING THAT PROMISING IDEAS MOVE THROUGH THE FULL RESEARCH PATHWAY: UNCOVERING DISEASE BIOLOGY, IDENTIFYING AND REFINING NEW THERAPEUTIC TARGETS OR BIOMARKERS, VALIDATING THEM IN RIGOROUS MODELS, GENERATING TRANSLATIONAL DATA, AND PREPARING THE STRONGEST CANDIDATES FOR CLINICAL DEVELOPMENT. OUR FUNDING ALLOCATION REFLECTS WHERE THE STRONGEST IDEAS EMERGE. THE DISTRIBUTION OF OUR FUNDING ISN'T SET BY QUOTAS OR PERCENTAGES. IT'S SHAPED BY WHERE THE MOST COMPELLING SCIENCE IS HAPPENING. EACH YEAR, WE INVEST IN THE PROPOSALS WITH THE CLEAREST BIOLOGICAL RATIONALE, THE STRONGEST EVIDENCE, AND THE GREATEST POTENTIAL TO ADVANCE THE FIELD. RESEARCH WE ENABLE:TARGET ALS CONTINUES TO BREAK DOWN BARRIERS TO PROGRESS BY OFFERING NO-STRINGS-ATTACHED ACCESS TO CRITICAL TOOLS AND RESOURCES THROUGH OUR RESEARCH CORES. THESE SHARED RESOURCES ADDRESS LONGSTANDING CHALLENGES IN ALS RESEARCH THAT HAVE HISTORICALLY SLOWED DISCOVERY: LIMITED ACCESS, HIGH COSTS, AND LACK OF STANDARDIZATION. THE RESEARCH CORES ACCELERATE DRUG DISCOVERY AND BIOMARKER DEVELOPMENT WHILE FOSTERING COLLABORATION ACROSS THE GLOBAL ALS COMMUNITY. IN 2025, TARGET ALS INVESTED OVER $8M TO EMPOWER SCIENTISTS WITH THE MATERIALS, DATA, AND INFRASTRUCTURE THEY NEED TO DRIVE PROGRESS FROM THE BENCH TO THE CLINIC. FROM OUR POSTMORTEM TISSUE CORE TO THE LONGITUDINAL BIOFLUIDS CORE POWERED BY OUR GLOBAL NATURAL HISTORY STUDY (GNHS) AND OPEN-ACCESS DATA ENGINE, TARGET ALS PROVIDES RESEARCHERS WORLDWIDE WITH STATE-OF-THE-ART BIOSAMPLES, DATASETS, ANTIBODIES, AND MORE, WITH NO REACHTHROUGH ON INTELLECTUAL PROPERTY (IP). THESE TOOLS ARE AVAILABLE TO BOTH ACADEMIA AND INDUSTRY, ENSURING THAT SCIENTIFIC BREAKTHROUGHS CAN MOVE SWIFTLY AND COLLABORATIVELY TOWARD THERAPIES FOR PEOPLE LIVING WITH ALS. TO DATE, MORE THAN 1,750 PROJECTS HAVE RELIED ON THESE RESOURCES, SPANNING BASIC BIOLOGY, TARGET VALIDATION, BIOMARKER DISCOVERY, AND THERAPEUTIC DEVELOPMENT. AND THE MOMENTUM IS ONLY GROWING: OVER 500 RESEARCHERS HAVE ACCESSED OUR DATA ENGINE, WHILE GLOBAL CONSORTIA OF PREEMINENT SCIENTISTS ARE WORKING TOGETHER WITH TARGET ALS FUNDS TO SHARE DATA, REPLICATE FINDINGS, AND AMPLIFY IMPACT.RESEARCH WE CONDUCT:ALS IS A DISEASE THAT AFFECTS PEOPLE OF EVERY RACE AND ETHNICITY AROUND THE WORLD. HOWEVER, CLINICAL TRIALS ENROLL PRIMARILY PEOPLE OF WHITE, EUROPEAN DESCENT RESULTING IN A BIASED, INCOMPLETE VIEW OF DISEASE BIOLOGY ACROSS THE ALS GLOBAL POPULATION. THE ALS GLOBAL RESEARCH INITIATIVE (AGRI) IS THE ONLY COMPREHENSIVE, GLOBAL RESEARCH EFFORT THAT BRINGS TOGETHER TWO COMPLEMENTARY CLINICAL STUDIES DESIGNED TO UNCOVER THE CAUSES OF ALS AND IDENTIFY NEW BIOMARKERS THAT CAN DIAGNOSE THE DISEASE EARLIER, TRACK ITS PROGRESSION, AND PREDICT OUTCOMES. THESE STUDIES PROVIDE RESEARCHERS UNPRECEDENTED ACCESS TO PATIENT DATA AND BIOSAMPLES WORLDWIDE, RAPIDLY ACCELERATING NEW DISCOVERIES AND DRIVING PROGRESS TOWARD MORE EFFECTIVE THERAPIES. ULTIMATELY, INCLUSIVE RESEARCH STRENGTHENS SCIENTIFIC VALIDITY, IMPROVES PATIENT OUTCOMES, AND HELPS ENSURE THAT BREAKTHROUGHS BENEFIT EVERYONE, NOT JUST A SUBSET OF THE POPULATION. THROUGHOUT THE YEAR, WE INVESTED OVER $1.5M, WHICH FUELED AGRI'S BOLD GOAL: BRING THE WORLD TOGETHER TO TACKLE ALS FROM EVERY ANGLE. THROUGH OUR GLOBAL NATURAL HISTORY STUDY (GNHS) AND COMMUNITYBASED POP-UP CLINICS, WE'RE MAKING ALS RESEARCH MORE INCLUSIVE, MORE IMMEDIATE, AND MORE COLLABORATIVE THAN EVER BEFORE. | Desc |
| Total Program Service Expenses | $21,006,355 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | 0 | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (1) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 18 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 18 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 14 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 14 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KENNETH DEVANEY | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 6465922541 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 244 MADISON AVE 1025 | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10016 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (22 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|
| DANIEL L DOCTOROFF | |||||||
| BOARD CHAIR | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| JOHN DUNLOP | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| BRAD S KARP | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ZACH W HALL | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| STORY LANDIS | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| SARAH SHEIKH | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ALISA DOCTOROFF | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ALLISON JAFFIN | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ANDY BERNDT | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| CHRIS HERNDERSON | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| RICHARD HARGREAVES | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| CAROL HO | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| STACY WENINGER | |||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| ERIC DANE | |||||||
| BOARD MEMBER (AS OF 12/25) | 1.00 | Yes (X) | $0 | $0 | $0 | ||
| MANISH RAISINGHANI | |||||||
| PRESIDENT | 40.00 | Yes (X) | $404,414 | $0 | $40,841 | ||
| KENNETH DEVANEY | |||||||
| CHIEF OPERATING OFFICER | 40.00 | Yes (X) | $293,699 | $0 | $35,305 | ||
| JESSICA CHAPMAN | |||||||
| CHIEF DEVELOPMENT OFFICER | 40.00 | Yes (X) | $240,468 | $0 | $68,984 | ||
| AMY EASTON | |||||||
| VICE PRESIDENT, RESEARCH GROUPS | 40.00 | $299,898 | $0 | $68,984 | Yes (X) | ||
| YULIYA RZAD | |||||||
| CHIEF GRANTS OFFICER | 40.00 | $206,142 | $0 | $43,617 | Yes (X) | ||
| CHRISTINE PROUTY ARANYOS | |||||||
| DIRECTOR OF PHILANTHROPY | 40.00 | $165,242 | $0 | $62,251 | Yes (X) | ||
| LAURA DUGOM | |||||||
| ASSOCIATE DIRECTOR CLINICAL RESEARCH | 40.00 | $168,857 | $0 | $29,063 | Yes (X) | ||
| STEPHANIE ISHOO | |||||||
| DIRECTOR OF MARKETING & COMMUNICATIONS | 40.00 | $165,555 | $0 | $27,314 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,944,275 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $376,359 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 12 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $29,724,385 | AllOtherContributionsAmt |
| Noncash Contributions | $6,226,324 | NoncashContributionsAmt |
| Total Contributions | $29,724,385 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,253,081 | TotalRevenueColumnAmt |
| Exclusion | $3,253,081 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $15,396,004 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $15,113,710 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $282,294 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $282,294 | TotalRevenueColumnAmt |
| Exclusion | $282,294 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | OTHER INCOME | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $2,225 | TotalRevenueColumnAmt |
| Exclusion | $2,225 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $2,225 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $33,261,985 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $3,537,600 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,067,691 | TotalAmt |
| Program Services | $13,067,691 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,698,177 | TotalAmt |
| Program Services | $5,698,177 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $970,997 | TotalAmt |
| Program Services | $350,438 | ProgramServicesAmt |
| Management And General | $329,004 | ManagementAndGeneralAmt |
| Fundraising | $291,555 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,080,679 | TotalAmt |
| Program Services | $425,646 | ProgramServicesAmt |
| Management And General | $1,249,279 | ManagementAndGeneralAmt |
| Fundraising | $405,754 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $104,034 | TotalAmt |
| Program Services | $21,282 | ProgramServicesAmt |
| Management And General | $62,464 | ManagementAndGeneralAmt |
| Fundraising | $20,288 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $499,114 | TotalAmt |
| Program Services | $77,981 | ProgramServicesAmt |
| Management And General | $326,462 | ManagementAndGeneralAmt |
| Fundraising | $94,671 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $200,843 | TotalAmt |
| Program Services | $48,967 | ProgramServicesAmt |
| Management And General | $104,303 | ManagementAndGeneralAmt |
| Fundraising | $47,573 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $32,006 | TotalAmt |
| Management And General | $32,006 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $91,859 | TotalAmt |
| Management And General | $91,859 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $176,591 | TotalAmt |
| Management And General | $176,591 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $258,252 | TotalAmt |
| Management And General | $194,765 | ManagementAndGeneralAmt |
| Fundraising | $63,487 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $802,482 | TotalAmt |
| Fundraising | $802,482 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $99,032 | TotalAmt |
| Program Services | $6,004 | ProgramServicesAmt |
| Management And General | $76,414 | ManagementAndGeneralAmt |
| Fundraising | $16,614 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $143,162 | TotalAmt |
| Management And General | $143,162 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $94,181 | TotalAmt |
| Program Services | $20,974 | ProgramServicesAmt |
| Management And General | $58,708 | ManagementAndGeneralAmt |
| Fundraising | $14,499 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,299,614 | TotalAmt |
| Program Services | $1,289,195 | ProgramServicesAmt |
| Management And General | $8,575 | ManagementAndGeneralAmt |
| Fundraising | $1,844 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $25,618,714 | TotalAmt |
| Program Services | $21,006,355 | ProgramServicesAmt |
| Management And General | $2,853,592 | ManagementAndGeneralAmt |
| Fundraising | $1,758,767 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,137,916 | BOYAmt |
| EOY | $3,278,742 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,351,865 | BOYAmt |
| EOY | $4,679,056 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $49,311,907 | BOYAmt |
| EOY | $45,694,945 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $250,000 | BOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $76,751 | BOYAmt |
| EOY | $75,597 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $68,783,323 | BOYAmt |
| EOY | $83,184,297 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $128,911,762 | BOYAmt |
| EOY | $136,912,637 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $33,343 | BOYAmt |
| EOY | $25,316 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,318,332 | BOYAmt |
| EOY | $1,828,304 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,351,675 | BOYAmt |
| EOY | $1,853,620 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $81,346,621 | BOYAmt |
| EOY | $91,694,347 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $43,213,466 | BOYAmt |
| EOY | $43,364,670 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $124,560,087 | BOYAmt |
| EOY | $135,059,017 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $128,911,762 | BOYAmt |
| EOY | $136,912,637 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $7,643,271 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $2,855,659 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | 0 | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $6,884,826 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $98,356,585 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $79,162,687 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $47,902,882 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $29,724,385 | CurrentTaxYearAmt |
| Total | $262,031,365 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $6,884,826 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $98,356,585 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $79,162,687 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $47,902,882 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $29,724,385 | CurrentTaxYearAmt |
| Total | $262,031,365 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $33,043,073 | SubstantialContributorsTotAmt |
| Public Support Total170 | $228,988,292 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,174 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $24,092 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $407,954 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,201,600 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $955,309 | CurrentTaxYearAmt |
| Total | $3,592,129 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $67,784 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $392 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year | $2,224 | CurrentTaxYearAmt |
| Total | $70,400 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $265,693,894 | TotalSupportAmt |
| Public Support CY170 | 0.86190 | PublicSupportCY170Pct |
| Public Support PY170 | 0.86670 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
Other Securities OtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | INVESTMENTS | Desc |
| Book Value | $83,184,297 | BookValueAmt |
| Method Valuation | C | MethodValuationCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $83,184,297 | TotalBookValueSecuritiesAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $35,941,053 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $2,855,659 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | $2,855,659 | RevenueNotReportedAmt |
| Revenue Subtotal | $33,085,394 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $176,591 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $176,591 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $33,261,985 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $25,442,123 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $25,442,123 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $176,591 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $176,591 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $25,618,714 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE FOUNDATION IS EXEMPT FROM INCOME TAXES AS A PUBLIC CHARITY UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). MANAGEMENT BELIEVES THAT THE FOUNDATION OPERATES IN A MANNER CONSISTENT WITH ITS TAX-EXEMPT STATUS AT BOTH THE STATE AND FEDERAL LEVELS. THE FOUNDATION ANNUALLY FILES IRS FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, REPORTING VARIOUS INFORMATION THAT THE IRS USES TO MONITOR THE ACTIVITIES OF TAX-EXEMPT ENTITIES. THESE TAX RETURNS ARE SUBJECT TO REVIEW BY THE TAXING AUTHORITIES, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THEY WERE FILED. THE FOUNDATION CURRENTLY HAS NO TAX EXAMINATIONS IN PROGRESS. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | GRANTS TO RECIPIENTS, PROGRAM SERVICES | DATA ENGINE | |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTS TO RECIPIENTS & PROGRAM SERVICES | DATA ENGINE & POSTMORTEM TISSUE CORE | $213,943 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | GRANTS TO RECIPIENTS | IN VIVO TARGET VALIDATION PROJECTS, DATA ENGINE, POSTMORTEM TISSUE CORE, LONGITUDINAL BIOFLUIDS CORE, REAGENTS CORE | $4,793,803 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | GRANTS TO RECIPIENTS & PROGRAM SERVICES | DATA ENGINE, POSTMORTEM TISSUE CORE, REAGENTS CORE | $605,978 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | DATA ENGINE, POSTMORTEM TISSUE CORE, REAGENTS CORE | |
| SOUTH ASIA | 0 | 0 | GRANTS TO RECIPIENTS & PROGRAM SERVICES | DATA ENGINE | $84,453 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | DATA ENGINE |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $5,698,177 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $5,698,177 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (33 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt | Description Of Non Cash AsstDescriptionOfNonCashAsstTxt | Valuation Method UsedValuationMethodUsedDesc |
|---|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $95,494 | CASH | $0 | ||
| SOUTH ASIA | SCIENTIFIC RESEARCH | $42,325 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $259,400 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $50,000 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $120,000 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $229,925 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $0 | $222,965 | IN VIVO TARGET VALIDAITON STUDY | FMV | |
| MIDDLE EAST AND NORTH AFRICA | SCIENTIFIC RESEARCH | $129,979 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $129,124 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $119,995 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $150,000 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $384,322 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $125,000 | CASH | $0 | ||
| SOUTH ASIA | SCIENTIFIC RESEARCH | $42,128 | CASH | $0 | ||
| EAST ASIA AND THE PACIFIC | SCIENTIFIC RESEARCH | $125,000 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $130,520 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $0 | $108,456 | IN VIVO TARGET VALIDAITON STUDY | FMV | |
| EAST ASIA AND THE PACIFIC | SCIENTIFIC RESEARCH | $67,357 | CASH | $0 | ||
| MIDDLE EAST AND NORTH AFRICA | SCIENTIFIC RESEARCH | $100,000 | CASH | $0 | ||
| MIDDLE EAST AND NORTH AFRICA | SCIENTIFIC RESEARCH | $140,000 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $215,148 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $95,844 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $0 | $187,371 | IN VIVO TARGET VALIDAITON STUDY | FMV | |
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $342,360 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $149,896 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $387,423 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $124,953 | CASH | $0 | ||
| EAST ASIA AND THE PACIFIC | SCIENTIFIC RESEARCH | $21,586 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $129,935 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $100,000 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $130,000 | CASH | $0 | ||
| EUROPE (INCLUDING ICELAND & GREENLAND) | SCIENTIFIC RESEARCH | $371,622 | CASH | $0 | ||
| MIDDLE EAST AND NORTH AFRICA | SCIENTIFIC RESEARCH | $235,999 | CASH | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 31 | Total501c3OrgCnt |
| Total Other Org | 2 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (47 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc |
|---|---|---|---|---|---|---|---|---|---|---|
| CEDARS-SINAI MEDICAL CENTER | ||||||||||
| 8700 BEVERLY BLVD 2416 | LOS ANGELES | CA | 90048 | 951644600 | 501(C)3 | $116,550 | $0 | SCIENTIFIC RESEARCH | ||
| COLUMBIA UNIVERSITY | ||||||||||
| 630 WEST 168TH STREET | NEW YORK | NY | 10032 | 133948652 | 501(C)3 | $575,116 | $0 | SCIENTIFIC RESEARCH | ||
| REGENTS OF THE UNIVERSITY OF CALIFORNIA AT SAN DIEGO | ||||||||||
| 9500 GILMAN DR | LA JOLLA | CA | 92093 | 956006144 | 501(C)3 | $461,402 | $0 | SCIENTIFIC RESEARCH | ||
| BANNER SUN HEALTH RESEARCH INSTITUTE | ||||||||||
| 1111 E MCDOWELL RD | PHOENIX | AZ | 85006 | 450233470 | 501(C)3 | $202,642 | $0 | SCIENTIFIC RESEARCH | ||
| BAYLOR COLLEGE OF MEDICINE | ||||||||||
| 1102 BATES AVENUE | HOUSTON | TX | 77030 | 741613878 | 501(C)3 | $60,000 | $0 | SCIENTIFIC RESEARCH | ||
| BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | ||||||||||
| HENRY ADMINISTRATION BUILDING | URBANA | IL | 61801 | 376000511 | 501(C)3 | $200,000 | $0 | SCIENTIFIC RESEARCH | ||
| DENALI THERAPEUTICS | ||||||||||
| 161 OYSTER POINT BLVD | SAN FRANCISCO | CA | 94080 | 463872213 | 501(C)3 | $100,000 | $0 | SCIENTIFIC RESEARCH | ||
| DIGNITY HEALTH | ||||||||||
| 350 WEST THOMAS ROAD | PHOENIX | CA | 85013 | 941196203 | 501(C)3 | $800,313 | $0 | SCIENTIFIC RESEARCH | ||
| EMORY UNIVERSITY | ||||||||||
| 1762 CLIFTON ROAD SUITE 1400 | ATLANTA | GA | 30322 | 580566256 | 501(C)3 | $386,594 | $0 | SCIENTIFIC RESEARCH | ||
| GEORGETOWN UNIVERSITY | ||||||||||
| 3700 O ST NW | WASHINGTON | DC | 20057 | 530196603 | 501(C)3 | $103,074 | $0 | SCIENTIFIC RESEARCH | ||
| HARVARD UNIVERSITY | ||||||||||
| 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138 | 042103580 | 501(C)3 | $125,000 | $0 | SCIENTIFIC RESEARCH | ||
| JOHN HOPKINS UNIVERSITY | ||||||||||
| 725 WOLFE STREET | BALTIMORE | MD | 21205 | 520595110 | 501(C)3 | $253,263 | $0 | SCIENTIFIC RESEARCH | ||
| LADDER THERAPEUTICS INC | ||||||||||
| 1030 BRITTAN AVE | SAN CARLOS | CA | 94070 | 861878229 | $140,000 | $0 | SCIENTIFIC RESEARCH | |||
| MAYO CLINIC JACKSONVILLE | ||||||||||
| 4500 SAN PABLO ROAD | SOUTH JACKSONVILLE | FL | 32224 | 593337028 | 501(C)3 | $579,510 | $0 | SCIENTIFIC RESEARCH | ||
| NATIONAL INSTITUTE OF HEALTH | ||||||||||
| 35A CONVENT DRIVE | BETHESDA | MD | 20892 | 521983273 | GOVERNMENT | $110,300 | $0 | SCIENTIFIC RESEARCH | ||
| NEURAL STEM CELL INSTITUTE | ||||||||||
| ONE DISCOVERY DRIVE | RENSSELAER | NY | 12144 | 203654626 | 501(C)3 | $49,273 | $0 | SCIENTIFIC RESEARCH | ||
| NEURODEX INC | ||||||||||
| 27 STRATHMORE ROAD | NATICK | MA | 01760 | 043230035 | $128,200 | $0 | SCIENTIFIC RESEARCH | |||
| NORTHWESTERN UNIVERSITY | ||||||||||
| 1201 DAVIS STREET | CHICAGO | IL | 60208 | 362167817 | 501(C)3 | $438,968 | $0 | SCIENTIFIC RESEARCH | ||
| NOVA SOUTHEASTERN UNIVERSITY | ||||||||||
| 3300 S UNIVERSITY DRIVE | FORT LAUDERDALE | FL | 33328 | 591083502 | 501(C)3 | $103,087 | $0 | SCIENTIFIC RESEARCH | ||
| NUCYRNA THERAPEUTICS INC | ||||||||||
| 1296 WORCESTER RD APT 2303 | FRAMINGHAM | MA | 01702 | 992059436 | $200,000 | $0 | SCIENTIFIC RESEARCH | |||
| PRINCETON UNIVERSITY | ||||||||||
| 701 CARNEGIE CENTER SUITE 445 | PRINCETON | NJ | 08540 | 210634501 | 501(C)3 | $60,000 | $0 | SCIENTIFIC RESEARCH | ||
| PURDUE UNIVERSITY | ||||||||||
| 610 PURDUE MALL | WEST LAFAYETTE | IN | 47907 | 351052049 | 501(C)3 | $60,000 | $0 | SCIENTIFIC RESEARCH | ||
| QUR ALIS | ||||||||||
| 35 CAMBRIDGEPARK DRIVE 300 | CAMBRIDGE | MA | 02140 | 814722156 | $200,000 | $0 | SCIENTIFIC RESEARCH | |||
| REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE | ||||||||||
| 419 SOUTH CIRCLE VIEW DRIVE | IRVINE | CA | 92617 | 952226406 | 501(C)3 | $200,000 | $0 | SCIENTIFIC RESEARCH | ||
| REGENTS OF THE UNIVERSITY OF MICHIGAN | ||||||||||
| 3003 S STATE STREET SUITE 8000A | ANN ARBOR | MI | 48109 | 386006309 | 501(C)3 | $255,000 | $0 | SCIENTIFIC RESEARCH | ||
| REGENTS UNIVERSITY OF CALIFORNIA | ||||||||||
| CHARLES E YOUNG DRIVE | WEST LOS ANGELES | CA | 90095 | 956006143 | 501(C)3 | $150,000 | $0 | SCIENTIFIC RESEARCH | ||
| ROME THERAPEUTICS | ||||||||||
| 201 BROOKLINE AVENUE SUITE 1001 | BOSTON | MA | 02215 | 833633163 | $0 | $184,701 | SCIENTIFIC RESEARCH | COST | ACTUAL COST TO INTRODUCE STUDY REPORT INVOICED BY VENDOR | |
| SAINT LOUIS UNIVERSITY | ||||||||||
| 1100 SOUTH GRAND BLVD | ST LOUIS | MO | 63101 | 430654872 | 501(C)3 | $125,000 | $0 | SCIENTIFIC RESEARCH | ||
| STANFORD UNIVERSITY | ||||||||||
| 1291 WELCH ROAD | PALO ALTO | CA | 94305 | 941156365 | 501(C)3 | $185,000 | $0 | SCIENTIFIC RESEARCH | ||
| SYNOLIGO BIOTECHNOLOGIES | ||||||||||
| 101 SOUTHCENTER COURT SUITE 800 | MORRISVILLE | NC | 27560 | 883196281 | $100,000 | $0 | SCIENTIFIC RESEARCH | |||
| THE MASSACHUSETTS GENERAL HOSPITAL | ||||||||||
| 125 NASHUA STREET SUITE 540 | BOSTON | MA | 02114 | 042697983 | 501(C)3 | $375,000 | $0 | SCIENTIFIC RESEARCH | ||
| THE UNIVERSITY OF ALABAMA AT BIRMINGHAM | ||||||||||
| 1720 2ND AVE S AB1230 | BIRMINGHAM | AL | 35294 | 636005396 | 501(C)3 | $298,217 | $0 | SCIENTIFIC RESEARCH | ||
| THOMAS JEFFERSON UNIVERSITY | ||||||||||
| 233 SOUTH 10TH STREET | PHILADELPHIA | PA | 19107 | 231352651 | 501(C)3 | $89,962 | $0 | SCIENTIFIC RESEARCH | ||
| TRACE NEUROSCIENCE | ||||||||||
| 750 GATEWAY BLVD SUITE 200 | SAN FRANCISCO | CA | 94080 | 990762304 | $105,000 | $0 | SCIENTIFIC RESEARCH | |||
| TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | ||||||||||
| 445 NORTH 5TH STREET | PHOENIX | AZ | 85004 | 753065445 | 501(C)3 | $125,000 | $0 | SCIENTIFIC RESEARCH | ||
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||
| 422 CURIE BOULEVARD | PHILADELPHIA | PA | 19104 | 231352685 | 501(C)3 | $0 | $210,429 | SCIENTIFIC RESEARCH | COST | ACTUAL COST TO INTRODUCE STUDY REPORT INVOICED BY VENDOR |
| TWILIGHT NEURO | ||||||||||
| 100 CUMMINGS CENTER SUITE 207-209 | BEVERLY | MA | 01915 | 920566170 | $129,400 | $0 | SCIENTIFIC RESEARCH | |||
| TWIST BIOSCIENCE | ||||||||||
| 681 GATEWAY BLVD | SAN FRANCISCO | CA | 94080 | 462058888 | $100,000 | $0 | SCIENTIFIC RESEARCH | |||
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||||||||||
| LOCKBOX 45339 | SAN FRANCISCO | CA | 94145 | 946036493 | 501(C)3 | $731,472 | $0 | SCIENTIFIC RESEARCH | ||
| UNIVERSITY OF CALIFORNIA SANTA BARBARA | ||||||||||
| 6129 BIOLOGY II | SANTA BARBARA | CA | 93106 | 956006145 | 501(C)3 | $290,000 | $0 | SCIENTIFIC RESEARCH | ||
| UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL | ||||||||||
| 366 PLANTATION STREET | WORCESTER | MA | 01605 | 043167352 | 501(C)3 | $100,000 | $0 | SCIENTIFIC RESEARCH | ||
| UNIVERSITY OF PITTSBURGH | ||||||||||
| 3501 FIFTH AVENUE | PITTSBURGH | PA | 15213 | 250965591 | $125,000 | $0 | SCIENTIFIC RESEARCH | |||
| UNIVERSITY OF PUERTO RICO | ||||||||||
| PO BOX 365067 | SAN JUAN | PR | 00956 | 660433762 | 501(C)3 | $93,789 | $0 | SCIENTIFIC RESEARCH | ||
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||||||||||
| 3720 S FLOWER ST FL3 | LOS ANGELES | CA | 90089 | 951642394 | 501(C)3 | $260,000 | $0 | SCIENTIFIC RESEARCH | ||
| UNIVERSITY OF VERMONTH AND STATE AGRICULTURAL COLLEGE | ||||||||||
| BEAUMONT AVENUE | BURLINGTON | VT | 05405 | 030179440 | 501(C)3 | $101,736 | $0 | SCIENTIFIC RESEARCH | ||
| WASHINGTON UNIVERSITY | ||||||||||
| 660 SOUTH EUCLID AVENUE | ST LOUIS | MO | 63110 | 430653611 | 501(C)3 | $213,046 | $0 | SCIENTIFIC RESEARCH | ||
| YALE UNIVERSITY | ||||||||||
| PO BOX 2038 | NEW HAVEN | CT | 06521 | 275024008 | 501(C)3 | $100,000 | $0 | SCIENTIFIC RESEARCH | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 36 | Total501c3OrgCnt |
| Total Other Org | 11 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION USES GRANTS MANAGEMENT SOFTWARE, WHERE ALL INFORMATION IS SAVED RELATING TO EACH RECEIVED APPLICATION. THIS INCLUDES THE SCOPE OF WORK / RESEARCH PROPOSAL, BUDGET, SIGNED CONTRACTS AND AWARD LETTERS, ORGANIZATIONAL INFORMATION SUCH AS EIN AND ADDRESS, PAYMENT RECORDS RECONCILED WITH THE ORGANIZATION'S FINANCIAL SYSTEM, AND SCORED REVIEWS BY ITS INDEPENDENT REVIEW COMMITTEE. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MANISH RAISINGHANI | ||||||||||||||
| PRESIDENT | $404,414 | $0 | $0 | $0 | $0 | $0 | $20,221 | $0 | $20,620 | $0 | $445,255 | $0 | $0 | $0 |
| AMY EASTON | ||||||||||||||
| VICE PRESIDENT, RESEARCH GROUPS | $299,898 | $0 | $0 | $0 | $0 | $0 | $14,995 | $0 | $53,989 | $0 | $368,882 | $0 | $0 | $0 |
| KENNETH DEVANEY | ||||||||||||||
| CHIEF OPERATING OFFICER | $293,699 | $0 | $0 | $0 | $0 | $0 | $14,685 | $0 | $20,620 | $0 | $329,004 | $0 | $0 | $0 |
| JESSICA CHAPMAN | ||||||||||||||
| CHIEF DEVELOPMENT OFFICER | $240,468 | $0 | $0 | $0 | $0 | $0 | $14,995 | $0 | $53,989 | $0 | $309,452 | $0 | $0 | $0 |
| YULIYA RZAD | ||||||||||||||
| CHIEF GRANTS OFFICER | $206,142 | $0 | $0 | $0 | $0 | $0 | $10,307 | $0 | $33,310 | $0 | $249,759 | $0 | $0 | $0 |
| CHRISTINE PROUTY ARANYOS | ||||||||||||||
| DIRECTOR OF PHILANTHROPY | $165,242 | $0 | $0 | $0 | $0 | $0 | $8,262 | $0 | $53,989 | $0 | $227,493 | $0 | $0 | $0 |
| LAURA DUGOM | ||||||||||||||
| ASSOCIATE DIRECTOR CLINICAL RESEARCH | $168,857 | $0 | $0 | $0 | $0 | $0 | $8,443 | $0 | $20,620 | $0 | $197,920 | $0 | $0 | $0 |
| STEPHANIE ISHOO | ||||||||||||||
| DIRECTOR OF MARKETING & COMMUNICATIO | $165,555 | $0 | $0 | $0 | $0 | $0 | $8,278 | $0 | $19,036 | $0 | $192,869 | $0 | $0 | $0 |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 16 | ContributionCnt |
| Noncash Contributions Rpt F990 | $6,226,324 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | TWO INDIVIDUALS SERVING AS OFFICERS/DIRECTORS OF THE ORGANIZATION ARE SPOUSES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS PREPARED BY THE EXTERNAL AUDITORS AND REVIEWED BY MANAGEMENT. ONCE ALL ARE SATISFIED WITH THE FORM, IT IS FINALIZED AND A COPY IS SENT TO ALL BOARD EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW PRIOR TO SUBMISSION. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE BOARD OF DIRECTORS ARE ASKED ANNUALLY TO REVIEW THE CONFLICT OF INTEREST POLICY, DISCLOSE ANY POTENTIAL CONFLICTS OF INTEREST AND SIGN-OFF THAT THEY UNDERSTAND THEIR OBLIGATIONS AS A MEMBER OF THE BOARD. THE CONFLICT OF INTEREST POLICY STATES THAT PERIODIC REVIEW BE PERFORMED EVALUATING WHETHER PARTNERSHIP, JOINT VENTURES OR THE LIKE CONFORM WITH THE ORGANIZATION'S WRITTEN POLICIES REGARDING UNAUTHORIZED PRIVATE BENEFIT AND EXCESS BENEFIT TRANSACTIONS. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE BOARD CONDUCTS A PERFORMANCE REVIEW AND EVALUATION OF THE PRESIDENT & CEO. THE REVIEW ALSO ESTABLISHES THE INDIVIDUAL'S COMPENSATION. THIS PROCESS INVOLVES THE EVALUATION OF THE INDIVIDUAL AND A REVIEW OF COMPENSATION OF COMPARABLE POSITIONS OBTAINED FROM COMPENSATION SURVEYS. THE BOARD'S DELIBERATION AND DECISION IS DISCUSSED IN EXECUTIVE SESSISION. THE PRESIDENT & CEO ESTABLISHES THE COMPENSATION OF THE SENIOR MANAGEMENT TEAM AND REVIEWS THE PERFORMANCE EVALUATIONS AND RECOMMENDED COMPENSATION WITH THE BOARD. THE EVALUATIONS AND COMPENSATION ARE DISCUSSED WITH THE BOARD ALTHOUGH NO VOTE OF APPROVAL OF THE PRESIDENT & CEO'S DECISION IS REQUIRED. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS (ARTICLES OF INCORPORATION AND BY-LAWS) AVAILABLE UPON REQUEST BY ELECTRONIC MAIL. THE TARGET ALS CONFLICT OF INTEREST POLICY IS AVAILABLE ON OUR WEBSITE: HTTPS://TARGETALS.ORG/OUR-TEAM/. SIMILARLY, ANNUAL FINANCIAL STATEMENTS ARE AVAILABLE HERE: HTTPS://TARGETALS.ORG/FINANCIAL-REPORTS/. |